🌱 KidneyEnergy.com

← brief for 2026-08-20 · Slowing decline

Masthead

Paper B Peer reviewed Small trial

Key takeaways

A study of 100 patients with AF and CKD found that using DOACs (direct oral anticoagulants) instead of warfarin did not reduce stroke risk and might increase bleeding. The study lasted 2 years. This finding challenges the use of DOACs in patients with advanced kidney disease.

Source

Paper · AJKD · 2026-09-01
https://www.ajkd.org/article/S0272-6386(26)01013-9/fulltext?rss=yes